TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2010

Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.

Herbert Y Meltzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.